Cellular transplantation: Future therapeutic options

Current Opinion in Cardiology

Volumn 22, Issue 2, 2007, Pages 104-110

  Allan, Rebecca ^a   Kass, Malek ^a   Glover, Christopher ^a   Haddad, Haissam ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Embryonic stem cells; Granulocyte colony stimulating factor; Percutaneous coronary intervention; Transplant

Indexed keywords

AZACITIDINE; GRANULOCYTE COLONY STIMULATING FACTOR; NITRIC OXIDE; PLACEBO; RETINOIC ACID; SOMATOMEDIN;

ACUTE HEART INFARCTION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC DISEASE; CLINICAL RESEARCH; CLINICAL STUDY; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; EMBRYONIC STEM CELL; ENGRAFTMENT; HEART EJECTION FRACTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEMATOPOIETIC STEM CELL; HUMAN; MUSCLE BIOPSY; MUSCLE REGENERATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

ANIMALS; BONE MARROW TRANSPLANTATION; ENDOTHELIUM, VASCULAR; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; STEM CELL TRANSPLANTATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33846886697     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3280210657     Document Type: Review

References (84)

1. Angelini P, Markwald RR. Stem cell treatment of the heart: a review of its current status on the brink of clinical experimentation. Tex Heart Inst J 2005; 32:479-488. This paper reviews the current data on cellular transplantation.
2. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005; 115:572-583. This paper explains the role of EPCs in producing various growth factors that could accelerate angiogenesis and reduce apoptosis rates.
3. Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circ Res 2002; 91:1092-1102.
4. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med 2002; 346:5-15.
5. Muller P, Pfeiffer P, Koglin J, et al. Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts. Circulation 2002; 106:31-35.
6. Glaser R, Lu MM, Neural N, et al. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation 2002; 106:17-19.
7. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344:1750-1757.
8. Deb A, Wang S, Skelding KA, et al. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation 2003; 107:1247-1249.
9. Fukada K, Yuasa S. Stem cells as a source of regenerative cardiomyocytes. Circ Res 2006; 98:1002-1013.
10. Murray CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 2005; 112:3174-3183.
11. Wang Q, Sjoquist P. Myocardial regeneration with stem cells: pharmacological possibilities for efficacy enhancement. Pharmacol Res 2006; 53:331-340.
12. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114:763-776.
13. Rosenthal N. Prometheus's vulture and the stem-cell promise. N Engl J Med 2003; 349:267-274.
14. Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998; 279:1528-1530.
15. Condorelli G, Borello U, De Angelis L, et al. Cardiomyocytes induced endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A 2001; 98:10733-10738.
16. Shi Q, Rafii S, Wu MH, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92:362-367.
17. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275:964-967.
18. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5:434-438.
19. Eglitis MA, Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S A 1997; 94:4080-4085.
20. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284:1168-1170.
21. Theise ND, Badve S, Saxena R, et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000; 32:11-16.
22. Alison MR, Poulsom R, Jeffery R, et al. Hepatocytes from nonhepatic adult stem cells. Nature 2000; 406:257.
23. Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999; 401:390-394.
24. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; 6:1229-1234.
25. To LB, Haylock DN, Simmons PJ, et al. The biology and clinical uses of blood stem cells. Blood 1997; 89:2233-2258.
26. Cogle CR, Wainman DA, Jorgensen ML, et al. Adult human hematopoietic cells provide functional hemangioblast activity. Blood 2004; 103:133-135.
27. Grant MB, Caballero S, Brown GA, et al. The contribution of adult hematopoietic stem cells to retinal neovascularization. Adv Exp Med Biol 2003; 522:37-45.
28. Grant MB, May WS, Caballero S, et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 2002; 8:607-612.
29. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410:701-705.
30. Balsam LB, Wagers AJ, Christensen JL, et al. Haematopoietic stem cells adopt mature hematopoietic fates in ischaemic myocardium. Nature 2004; 428:668-673.
31. Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004; 10:494-501.
32. Murray CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428:664-668.
33. Murry CE, Reinecke H, Pabon LM. Regeneration gaps: observations on stem cells and cardiac repair. J Am Coll Cardiol 2006; 47:1777-1785.
34. Wollert KC, Drexler H. Clinical applications of stem cells for the heart. Circ Res 2005; 96:151-163. This paper reviews the potential donor cells, mode of delivery, and their use in clinical setting.
35. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7:430-436.
36. Uemura R, Xu M, Ahmad N, et al. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 2006; 98:1414-1421.
37. Hagege A, Carrion C, Menasche P, et al. Viability and differentiation of autologous skeletal myoblast grafts in ischemic cardiomyopathy. Lancet 2003; 361:491-492.
38. Terada N, Hamazaki T, Oka M, et al. Bone marrow stem cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416:542-545.
39. Crosby JR, Kaminski WE, Schatteman G, et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000; 87:728-730.
40. Doetschman TC, Eistetter H, Katz M, et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 1985; 87:27-45.
41. Min J, Huang X, Xiang M, et al. Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction. J Thorac Cardiovasc Surg 2006; 131:889-897.
42. Menard C, Hagege AA, Agbulut O, et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 2005; 366:1005-1012.
43. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106:1913-1918.
44. Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) Trial. Circulation 2006; 113:1287-1294. In this study, a single dose of intracoronary BMCs did not provide long-term benefit on left ventricular systolic function after AMI compared with a randomized control group; however, the study suggests an acceleration of left ventricular ejection fraction recovery after AMI by BMC therapy.
45. Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006; 367:112-121.
46. Schachinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction (REPAIR-AMI). N Engl J Med 2006; 355:1210-1221. This study showed no effects of intracoronary injection of autologous mononuclear BMCs on global left ventricular function.
47. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction (ASTAMI). N Engl J Med 2006; 355:1199-1209.
48. Cleland JGF, Freemantle N, Coletta AP, et al. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE and PROACTIVE. Eur Heart J 2006; 8:105-110.
49. Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 2004; 44:1690-1699.
50. Orlic D, Kajstura J, Chimenti S, et al. Cytokine-mobilized stem cells traffic to infarcted hearts and regenerate functional myocardium resulting in improved survival [abstract]. Blood 2001; 98 (Suppl 1):810a.
51. Ripa RS, Jorgensen E, Wang Y, et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation 2006; 113:1983-1992. This study showed that BMSC mobilization with subcutaneous G-CSF is safe but did not lead to further improvement in ventricular function after AMI compared with the recovery observed in the placebo group.
52. Ince H, Petzsch M, Kleine HD, et al. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 2005; 112:3097-3106.
53. Zohlnhofer D, Ott I, Mehilli J, et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 2006; 295:1003-1010.
54. Rosenzweig A. Cardiac cell therapy: mixed results from mixed cells. N Engl J Med 2006; 355:1274-1277.
55. Tse H, Kwong Y, Chan JKF, et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003; 361:47-49.
56. Fuchs S, Satler LF, Kornowski R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease. J Am Coll Cardiol 2003; 41:1721-1724.
57. Perin EC, Dohmann HFR, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003; 107:2294-2302.
58. Beeres SL, Bax JJ, Dibbets P, et al. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia. J Nucl Med 2006; 47:574-580.
59. Briguori C, Reimers B, Sarais C, et al. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. Am Heart J 2006; 151:674-680.
60. Strauer BE, Brehm M, Zeus T, et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT study. J Am Coll Cardiol 2005; 46:1651-1658. This study demonstrates that functional and metabolic regeneration of infarcted and chronically avital tissue can be realized in humans by bone marrow mononuclear cell transplantation.
61. Assmus B, Honold J, Lehmann, et al. Transcoronary transplantation of progenitor cells and recovery of left ventricular function in patients with chronic ischemic heart disease: results of a randomized, controlled trial [abstract]. Circulation 2004; 110:III-238.
62. Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006; 355:1222-1232.
63. Gavira JJ, Herreros J, Perez A, et al. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1 year follow-up. J Thorac Cardiovasc Surg 2006; 131:799-804.
64. Hagege AA, Carrion C, Menasche P, et al. Viability and differentiation of autologous skeletal myoblast grafts in ischemic cardiomyopathy. Lancet 2003; 361:491-492.
65. Pagani FD, DerSimonian H, Zawadzka A, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003; 41:879-888.
66. Menasche P, Hagege AA, Vilquin J, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41:1078-1083.
67. Herreros J, Prosper F, Perez A, et al. Autologous intramyocardial injection of cultured skeletal muscle derived stem cells in patients with nonacute myocardial infarction. Eur Heart J 2003; 24:2012-2020.
68. Dib N, Michler RE, Pagani FD, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 2005; 112:1748-1755.
69. Patel AN, Geffner L, Vina RF, et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 2005; 130:1631-1638.
70. Steendijk P, Smits P, Valgimigli M, et al. Intramyocardial injection of skeletal myoblasts: long term follow-up with pressure-volume loops. Nat Clin Pract 2006; 3:S94-S100.
71. Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362:697-703.
72. Takahashi T, Lord B, Schulze PC, et al. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 2003; 107:1912-1916.
73. Wu X, Ding S, Ding Q, et al. Small molecules that induce cardiomyogenesis in embryonic stem cells. J Am Chem Soc 2004; 126:1590-1591.
74. Abbot JD, Huang Y, Liu D, et al. Stromal cell-derived factor-1a plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004; 110:3300-3305.
75. Lu L, Zhang JQ, Ramires FJ, et al. Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue. Biochem Biophys Res Commun 2004; 320:907-913.
76. Nadal-Ginard B, Kajstura J, Leri A, et al. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 2003; 92:139-150.
77. Heeschen C, Lehmann R, Honold J, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004; 109:1615-1622.
78. Rupp S, Badorff C, Koyanagi M, et al. Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. Basic Res Cardiol 2004; 99:61-68.
79. Spyridopoulos I, Haendeler J, Urbich C, et al. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 2004; 110:3136-3142.
80. Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9:1195-1201.
81. Martin CM, Meeson AP, Robertson SM, et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac CP cells in the developing and adult heart. Dev Biol 2004; 265:262-275.
82. Simons M. Angiogenesis: where do we stand now? Circulation 2005; 111:1556-1566.
83. Chen S, Fang W, Ye F, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004; 94:92-95.
84. Kang H, Kim H, Zhang S, et al. Effects of infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004; 363:751-756.